Multiplex Assay Kit for Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay)

PLA2G6; CaI-PLA2; GVI; INAD1; PNPLA9; Ca2+ Independent PLA2; 85 kDa Calcium-Independent Phospholipase A2; Phospholipase A2,group VI(Cytosolic,Calcium-Independent)

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-102 91
EDTA plasma(n=5) 78-96 88
heparin plasma(n=5) 81-94 86
sodium citrate plasma(n=5) 84-98 91

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-94% 80-101% 97-105% 78-104%
EDTA plasma(n=5) 95-102% 98-105% 83-95% 85-93%
heparin plasma(n=5) 87-104% 82-89% 91-98% 78-95%
sodium citrate plasma(n=5) 96-103% 80-99% 95-105% 97-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:iPLA2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Oncotarget Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression PubMed: 26061816
Bulletin of Experimental Biology and Medicine Polyunsaturated Fatty Acids and Their Correlations with Parameters of Oxidative/Antioxidant Potential of the Blood and Lipoprotein-Associated Phospholipase A2 in … Pubmed: 30417304
American Journal of Physiology. LungCellular and Molecular Physiology Effect of cooling on lung secretory phospholipase A2 activity in vitro, ex vivo and in vivo Pubmed: 30604626
Psychiatry Research An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia Doi: 10.1016/j.psychres.2019.01.095
Neurosurgery Is Admission Lipoprotein-Associated Phospholipase A2 a Novel Predictor of Vasospasm and Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage? Pubmed: 30850840
Journal of Medical Biochemistry CHANGES IN THE BLOOD FATTY-ACID PROFILE ASSOCIATED WITH OXIDATIVE-ANTIOXIDANT DISTURBANCES IN CORONARY ATHEROSCLEROSIS
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA411Hu01 Recombinant Phospholipase A2, Calcium Independent (iPLA2) Positive Control; Immunogen; SDS-PAGE; WB.
PAA411Hu01 Polyclonal Antibody to Phospholipase A2, Calcium Independent (iPLA2) WB; IHC; ICC; IP.
MAA411Hu22 Monoclonal Antibody to Phospholipase A2, Calcium Independent (iPLA2) WB; IHC; ICC; IP.
SEA411Hu ELISA Kit for Phospholipase A2, Calcium Independent (iPLA2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA411Hu Multiplex Assay Kit for Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.